These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3266779)

  • 21. An immunohistochemical and morphological study of amyloidosis complicating leprosy in Malaysian patients.
    Looi LM; Jayalakshim P; Lim KJ; Rajagopalan K
    Ann Acad Med Singap; 1988 Oct; 17(4):573-8. PubMed ID: 3223746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of leprosy in school-children and their family members in Berhampur.
    Sahoo A; Singh PC; Pattnaik S; Singh N
    Indian J Lepr; 2002; 74(2):137-43. PubMed ID: 12708732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of 6000 skin biopsies of the national leprosy control program in Mexico.
    Vargas-Ocampo F
    Int J Lepr Other Mycobact Dis; 2004 Dec; 72(4):427-36. PubMed ID: 15755197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Leprosy in The Netherlands in the period 1970-1991].
    Post E; chin-A-Lien RA; Bouman C; Naafs B; Faber WR
    Ned Tijdschr Geneeskd; 1994 Sep; 138(39):1960-3. PubMed ID: 7935946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis B antigen and antibody in patients with leprosy: a study of three resettlement villages in Thailand.
    Brown AE; Nelson KE; Smith TC; Suprasert S; Scollard DM
    Asian Pac J Allergy Immunol; 1989 Dec; 7(2):89-93. PubMed ID: 2624668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reflections on some aspects of leprosy among children in Brazil and in other countries.
    Bechelli LM; Pagnano PM
    Acta Leprol; 1990; 7(3):229-37. PubMed ID: 2151586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Occurrence and management of leprosy reaction in China in 2005.
    Shen J; Liu M; Zhou M; Wengzhong L
    Lepr Rev; 2009 Jun; 80(2):164-9. PubMed ID: 19743620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ocular complications in newly diagnosed borderline lepromatous and lepromatous leprosy patients: baseline profile of the Indian cohort.
    Daniel E; Koshy S; Rao GS; Rao PS
    Br J Ophthalmol; 2002 Dec; 86(12):1336-40. PubMed ID: 12446359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Leprosy--still a possibility in Denmark].
    Jensen AG; Bygbjerg IC; Jensen H; Ullman S
    Ugeskr Laeger; 1992 Jun; 154(24):1712-3. PubMed ID: 1632008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [An increase in Hansen's disease in northeastern Brazil].
    de Albuquerque MF; de Morais HM; Ximenes R
    Rev Saude Publica; 1989 Apr; 23(2):107-16. PubMed ID: 2617102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pattern of leprosy disabilities in Gorakhpur (Uttar Pradesh).
    Girdhar M; Arora SK; Mohan L; Mukhija RD
    Indian J Lepr; 1989 Oct; 61(4):503-13. PubMed ID: 2533603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical course of erythema nodosum leprosum: an 11-year cohort study in Hyderabad, India.
    Pocaterra L; Jain S; Reddy R; Muzaffarullah S; Torres O; Suneetha S; Lockwood DN
    Am J Trop Med Hyg; 2006 May; 74(5):868-79. PubMed ID: 16687695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coronary heart disease risk factors in Hansen's disease sufferers.
    Diamantopoulos EJ; Anthopoulos LP; Moulopoulos SD
    Clin Cardiol; 1992 Jun; 15(6):436-40. PubMed ID: 1617824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Leprosy in Africa. Current status and epidemiological significance].
    Stingl P
    Fortschr Med; 1992 Apr; 110(10):170-3. PubMed ID: 1577355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A study of the prevalence of smear-positive leprosy cases in a tertiary care center in the post-elimination phase of leprosy.
    Pradeep Nair S; Vidyadharan S
    Int J Dermatol; 2016 Jun; 55(6):680-6. PubMed ID: 26872564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A study of incidence of Australia antigen and derangements in liver function tests in leprosy.
    Nayak KC; Gupta RK; Aggarwal TD; Chadda VS; Kumar KK
    Indian J Lepr; 1989 Jan; 61(1):23-30. PubMed ID: 2703743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leprosy reactions in North-East Mexico: epidemiology and risk factors for chronic erythema nodosum leprosum.
    Cuellar-Barboza A; Cardenas-de la Garza JA; García-Lozano JA; Vera-Pineda R; Cruz-Gomez LG; Irabien-Zuniga M; Hernandez-Villarreal MJ; Welsh O; Gomez-Flores M; Ocampo-Candiani J
    J Eur Acad Dermatol Venereol; 2020 May; 34(5):e228-e229. PubMed ID: 31944428
    [No Abstract]   [Full Text] [Related]  

  • 39. Associations between HLA-DRB1 alleles and leprosy in an Indonesian population.
    Soebono H; Giphart MJ; Schreuder GM; Klatser PR; de Vries RR
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):190-6. PubMed ID: 9251590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ophthalmic findings of newly diagnosed leprosy patients in Istanbul Leprosy Hospital, Turkey.
    Cakiner T; Karaçorlu MA
    Acta Ophthalmol Scand; 1998 Feb; 76(1):100-2. PubMed ID: 9541444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.